International Stem Cell Corp., a California-based
biotech company developing novel stem cell-based therapies and biomedical
products, this morning said it will make an oral presentation on the
comprehensive results of its preclinical development of human parthenogenetic
neural stem cells (hPNSCs) for the treatment of Parkinson’s Disease at the
upcoming Neuroscience 2015 in Chicago.
The session, entitled, “Therapeutics of Parkinson’s
Disease: Preclinical Studies,” will take place October 20 from 8 a.m.-10:15
a.m. ET.
“The comprehensive data collected from our extensive
GLP studies serve as proof of safety and efficacy for our planned clinical
trial for the treatment of Parkinson’s Disease in Australia. We look forward to
providing an update on the status of our regulatory submission to the
Australian government in the near future,” Russell A. Kern, Ph.D. chief
scientific officer of ISCO, stated in the news release.
ISCO’s Parkinson’s disease program uses human
parthenogenetic neural stem cells (hPNSC), which are a novel therapeutic
cellular product derived from ISCO’s proprietary human pluripotent stem cells.
hPNSC are self-renewing multipotent cells that are precursors for the major
cells of the central nervous system. The ability of hPNSC to differentiate into
dopaminergic neurons and express neurotrophic factors to protect the
nigrostriatal system offers a new opportunity for the treatment of Parkinson’s
disease.
ISCO also produces and markets specialized cells and
growth media for therapeutic research worldwide through its subsidiary Lifeline
Cell Technology (www.lifelinecelltech.com), and stem cell-based skin care
products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com).
For more information visit
www.internationalstemcell.com
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment